4 patents
Utility
Crystalline salts of a B-RAF kinase inhibitor
12 Sep 23
The present invention is related to crystalline salts of N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide, a RAF kinase Inhibitor, useful in the treatment of cancer and other diseases.
Ulrike Werthmann, Gerd-Michael Maier, Bodo Betzemeier, Otmar Schaaf
Filed: 11 Mar 22
Utility
Crystalline Salts of a B-raf Kinase Inhibitor
30 Jun 22
The present invention is related to crystalline salts of N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide, a RAF kinase Inhibitor, useful in the treatment of cancer and other diseases.
Ulrike Werthmann, Gerd-Michael Maier, Bodo Betzemeier, Otmar Schaaf
Filed: 11 Mar 22
Utility
s5gpdsku25tg6f9fp7t4c90j zh
19 Apr 22
The present invention is related to crystalline salts of N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide, a RAF kinase Inhibitor, useful in the treatment of cancer and other diseases.
Ulrike Werthmann, Gerd-Michael Maier, Bodo Betzemeier, Otmar Schaaf
Filed: 26 Oct 18
Utility
xf6vnyuq0wo1onb6ivw85c42639y9dtsxorbxuy5b2mkb9ldtj8bogsb
9 Sep 20
The present invention is related to crystalline salts of N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide, a RAF kinase Inhibitor, useful in the treatment of cancer and other diseases.
Ulrike Werthmann, Gerd-Michael Maier, Bodo Betzemeier, Otmar Schaaf
Filed: 25 Oct 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first